Syngene International Reports Rs 32.2 Crore Q2 Profit, Recovers from Previous Quarter Loss
Syngene International reported a net profit of Rs 32.2 crore in the September quarter, marking a sequential recovery from a Rs 9 crore loss in the previous quarter but a 108% decline year-on-year from Rs 67.1 crore. Revenue fell 9% to Rs 832.7 crore compared to the prior year, while expenses also decreased. CEO Siddharth Mittal highlighted a 13% sequential revenue growth driven by the CDMO business and noted a new manufacturing agreement in the US, emphasizing ongoing efforts to enhance drug discovery and operational efficiency.
First-hand measurement across 2 sources
We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is neutral (52/100). Lens Score 36/100.
Outlets measured: english, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (52–52/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 27 Oct, 07:02 pm. Other outlets followed.
- 1